SCHEMBL14746398

SCHEMBL14746398

N#Cc1cccc(-c2ncco2)c1-c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.42
CHRNB2 P17787 1/20 0.41
CHRNA5 P30532 1/20 0.41
CHRNA4 P43681 1/20 0.41
KDM4E B2RXH2 5/20 0.40
GAA P10253 3/20 0.40
GLA P06280 2/20 0.40
ATM Q13315 1/20 0.40
PIM1 P11309 1/20 0.38
HPGDS O60760 1/20 0.38
HSD17B10 Q99714 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
BRCA1 P38398 1/20 0.37
RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29914913 0.79 ADORA2A (0.48) CYP11B2KDM4EGAAGLAATM
SCHEMBL29910019 0.76 BRD4 (0.42) HPGDSNPC1RAB9A
SCHEMBL368250 0.74 HPGDS (0.58) CHRNB2CHRNA5CHRNA4KDM4EHPGDS
SCHEMBL2146565 0.72 KDM4E (0.52) CYP11B2KDM4EGAAHSD17B10ALDH1A1
SCHEMBL20240078 0.72 KDM4E (0.49) CYP11B2KDM4EGAAGLAHSD17B10
SCHEMBL14856915 0.71 ESR2 (0.55) CYP11B2KDM4EGAAGLAHSD17B10
SCHEMBL30630392 0.71 ESR2 (0.55) CYP11B2KDM4EGAAGLAHSD17B10
SCHEMBL31264147 0.71 ESR2 (0.55) CYP11B2KDM4EGAAGLAHSD17B10
SCHEMBL28721464 0.70 KDM4E (0.50) CYP11B2KDM4EGAAGLAHSD17B10
SCHEMBL2146568 0.69 NISCH (0.49) CYP11B2KDM4EGAAGLAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751109-A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS Incyte Corporation (US) 2014-07-09 EP claimed
WO-2013033569-A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2013-03-07 WO claimed